Research Article
Evaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis
Table 3
Drug susceptibility testing results of each drug determined by use of the MGIT 960 system to be compared with L-J.
| Drug | Conc. evaluated (μg/mL) | No. of strains with indicated results by L-J/MGIT 960 | Sensitivity (%) | Specificity (%) | | | | |
| MXF | 0.5 | 19 | 36 | 0 | 4 | 100 | 90.0 | LEV | 1.0 | 18 | 37 | 1 | 3 | 94.7 | 92.5 | KM | 2.5 | 16 | 38 | 0 | 2 | 100 | 95.0 | CPM | 2.5 | 10 | 37 | 1 | 3 | 90.9 | 90.3 | ETH | 5.0 | 6 | 38 | 2 | 1 | 75.0 | 97.4 | PAS | 2.0 | 16 | 35 | 1 | 5 | 94.1 | 87.5 |
|
|